Inovio Pharma (INO) Announces INO-4212 Ebola Vaccine Generates Robust Immune Responses ...

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that its Ebola vaccine, INO-4212, was safe, tolerable, and generated strong T cell and … Full Article http://j.gs/5sTq

Click here to read full article